WHAT IS VIVITROL?

Opioid and alcohol dependence are chronic, relapsing brain diseases that can be devastating both psychologically and physically. While counseling can help patients work through the psychological aspects of dependence, medication may help address the physical changes in the brain.1 Prevent relapse in opioid-dependent patients with VIVITROL® (naltrexone for extended-release injectable suspension) – a non-addictive, once-monthly injectable medication – when used in conjunction with counseling, and following detoxification.2

MEET VIVITROL, AN ANTAGONIST TREATMENT OPTION

VIVITROL is indicated for:

  • Treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with VIVITROL. Patients should not be actively drinking at the time of initial VIVITROL administration.
  • Prevention of relapse to opioid dependence, following opioid detoxification.
  • VIVITROL should be part of a comprehensive management program that includes psychosocial support.

VIVITROL is contraindicated in patients:

  • Receiving opioid analgesics
  • With current physiologic opioid dependence
  • In acute opioid withdrawal
  • Who have failed the naloxone challenge test or have a positive urine screen for opioids
  • Who have exhibited hypersensitivity to naltrexone, polylactide-co-glycolide (PLG), carboxymethylcellulose, or any other components of the diluent
SEE HOW VIVITROL WORKS

VIVITROL EFFICACY AND SAFETY IN TREATING OPIOID DEPENDENCE

Read about the results of clinical trials >

VIVITROL EFFICACY AND SAFETY IN TREATING ALCOHOL DEPENDENCE

Read about the results of clinical trials >

VIVITROL is not right for everyone. There are significant risks from VIVITROL treatment, including risk of opioid overdose, injection site reactions and sudden opioid withdrawal.
See Important Safety Information below. Discuss all benefits and risks with your patients. See Prescribing Information. Review Medication Guide with your patients.

Request A Representative

REQUEST A REPRESENTATIVE

Request a visit from a VIVITROL representative to learn more about how VIVITROL may help your opioid- and alcohol-dependent patients.

REQUEST A REPRESENTATIVE

VIVITROL® Co-pay Savings Program

LEARN ABOUT THE VIVITROL® CO-PAY SAVINGS PROGRAM

Learn how the VIVITROL® Co-pay Savings Program may assist eligible* patients with out-of-pocket expenses for their VIVITROL prescriptions.

LEARN MORE

References:

  1. National Institute on Drug Abuse (NIDA). Drugs, brains, and behavior: the science of addiction. NIH publication 14-5605. https://www.drugabuse.gov/sites/default/files/soa_2014.pdf. Revised July 2014. Accessed April 11, 2019.
  2. VIVITROL [prescribing information and medication guide]. Waltham, MA: Alkermes, Inc; rev December 2018.
*Eligibility for Alkermes-Sponsored Co-pay Assistance: Offer valid only for prescriptions for FDA-approved indications. You must be at least 18 years old. If you are purchasing your VIVITROL® prescriptions with benefits from Medicare, including Medicare Part D or Medicare Advantage plans; Medicaid, including Medicaid Managed Care or Alternative Benefit Plans (“ABPs”) under the Affordable Care Act; Medigap; Veterans Administration (“VA”); Department of Defense (“DoD”); TriCare®; or any similar state funded programs such as medical or pharmaceutical assistance programs, you are not eligible for this offer. Void where prohibited by law, taxed or restricted. Subject to plan benefit design requirements. Alkermes, Inc. reserves the right to rescind, revoke or amend these offers without notice.